Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study
NEOPLASMA
Burkon, P; Kazda, T; Pospisil, P; Slavik, M; Kominek, L; Selingerova, I; Blakaj, DM; Prochazka, T; Vrzal, M; Rehak, Z; Slampa, P, 2019: Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study. NEOPLASMA 66(2), p. 315 - 325, doi: 10.4149/neo_2018_180731N558
CEITEC authors: